瑞康医药: 关于公司董事、董事会秘书及副总裁解除留置并变更为责令候查的公告

Core Points - The company announced the change of measures against its director, board secretary, and vice president from detention to a notice of investigation [1] - The company confirmed that its production and operation are normal, and the director can continue to fulfill his duties [1] Summary by Sections - Company Announcement: The company disclosed the change in measures taken against Mr. Li Zhe, indicating that the detention has been lifted and replaced with a notice of investigation [1] - Operational Status: The company stated that its production and operational conditions remain normal, allowing Mr. Li Zhe to perform his roles effectively [1] - Information Disclosure: The company specified its designated media for information disclosure, including several financial newspapers and a website [1]